Parkinson's Disease Trial, Recruiting NCT07336199 Sponsor: Ludwig-Maximilians - University of Munich Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07336199
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 35 and 80 years old
  • People who have been formally diagnosed with idiopathic Parkinson's disease (Parkinson's disease with no known cause) using recognised medical guidelines called the MDS criteria
  • People who have already had deep brain stimulation surgery on both sides of the brain, specifically in an area called the subthalamic nucleus (STN-DBS)
  • People whose implanted deep brain stimulation device is capable of recording brain signals (a type of device known as a sensing-enabled IPG)
  • People who are able to understand what the study involves and can communicate clearly with the research team
  • People who have given their written agreement to take part in the trial

Who may not be able to join:

  • People who have any condition that would prevent them from fully understanding what participation involves or from following the study procedures
  • People whose Parkinson's disease diagnosis does not meet the MDS criteria for idiopathic Parkinson's disease (confirm with trial site)
  • People who have a confirmed diagnosis of dementia according to standard international diagnostic guidelines (ICD-10)
  • People who have serious neurological, psychiatric, or other medical conditions that could interfere with taking part in the study or affect the results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4989440073901

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ludwig-Maximilians - University of Munich
Registry
ClinicalTrials.gov
Start date
2 December 2024
Est. completion
1 July 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Correlation between beta-band local field potentials and patient-reported DBS efficacy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov